AMGEN INC (1AMGN.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1AMGN - US0311621009 - Common Stock
278.45 EUR
-16.45 (-5.58%)
1AMGN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 82 industry peers in the Biotechnology industry. 1AMGN scores excellent on profitability, but there are concerns on its financial health. 1AMGN is not valued too expensively and it also shows a decent growth rate. 1AMGN also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
1AMGN had positive earnings in the past year.
In the past year 1AMGN had a positive cash flow from operations.
In the past 5 years 1AMGN has always been profitable.
In the past 5 years 1AMGN always reported a positive cash flow from operatings.
1.2 Ratios
With an excellent Return On Assets value of 7.77%, 1AMGN belongs to the best of the industry, outperforming 80.72% of the companies in the same industry.
1AMGN's Return On Equity of 72.82% is amongst the best of the industry. 1AMGN outperforms 100.00% of its industry peers.
The Return On Invested Capital of 1AMGN (15.39%) is better than 91.57% of its industry peers.
1AMGN had an Average Return On Invested Capital over the past 3 years of 13.04%. This is in line with the industry average of 12.14%.
The last Return On Invested Capital (15.39%) for 1AMGN is above the 3 year average (13.04%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.77% | ||
| ROE | 72.82% | ||
| ROIC | 15.39% |
ROA(3y)7.14%
ROA(5y)8.52%
ROE(3y)118.78%
ROE(5y)104.3%
ROIC(3y)13.04%
ROIC(5y)14.18%
1.3 Margins
1AMGN's Profit Margin of 19.47% is amongst the best of the industry. 1AMGN outperforms 81.93% of its industry peers.
In the last couple of years the Profit Margin of 1AMGN has declined.
1AMGN has a Operating Margin of 33.57%. This is amongst the best in the industry. 1AMGN outperforms 89.16% of its industry peers.
In the last couple of years the Operating Margin of 1AMGN has declined.
The Gross Margin of 1AMGN (72.06%) is better than 62.65% of its industry peers.
In the last couple of years the Gross Margin of 1AMGN has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 33.57% | ||
| PM (TTM) | 19.47% | ||
| GM | 72.06% |
OM growth 3Y-6.36%
OM growth 5Y-7.03%
PM growth 3Y-18.6%
PM growth 5Y-18.28%
GM growth 3Y-2.94%
GM growth 5Y-3.32%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), 1AMGN is creating value.
The number of shares outstanding for 1AMGN has been increased compared to 1 year ago.
1AMGN has less shares outstanding than it did 5 years ago.
1AMGN has a better debt/assets ratio than last year.
2.2 Solvency
1AMGN has a debt to FCF ratio of 4.28. This is a neutral value as 1AMGN would need 4.28 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.28, 1AMGN is in the better half of the industry, outperforming 78.31% of the companies in the same industry.
A Debt/Equity ratio of 5.45 is on the high side and indicates that 1AMGN has dependencies on debt financing.
1AMGN has a Debt to Equity ratio of 5.45. This is in the lower half of the industry: 1AMGN underperforms 67.47% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.45 | ||
| Debt/FCF | 4.28 | ||
| Altman-Z | N/A |
ROIC/WACC1.81
WACC8.49%
2.3 Liquidity
A Current Ratio of 1.28 indicates that 1AMGN should not have too much problems paying its short term obligations.
1AMGN has a Current ratio of 1.28. This is in the lower half of the industry: 1AMGN underperforms 67.47% of its industry peers.
A Quick Ratio of 0.99 indicates that 1AMGN may have some problems paying its short term obligations.
1AMGN has a worse Quick ratio (0.99) than 68.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.28 | ||
| Quick Ratio | 0.99 |
3. Growth
3.1 Past
1AMGN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.79%, which is quite good.
Measured over the past 5 years, 1AMGN shows a small growth in Earnings Per Share. The EPS has been growing by 5.97% on average per year.
1AMGN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.56%.
Measured over the past years, 1AMGN shows a small growth in Revenue. The Revenue has been growing by 7.43% on average per year.
EPS 1Y (TTM)13.79%
EPS 3Y5.02%
EPS 5Y5.97%
EPS Q2Q%1.08%
Revenue 1Y (TTM)10.56%
Revenue growth 3Y8.76%
Revenue growth 5Y7.43%
Sales Q2Q%12.4%
3.2 Future
1AMGN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.48% yearly.
Based on estimates for the next years, 1AMGN will show a small growth in Revenue. The Revenue will grow by 3.55% on average per year.
EPS Next Y9.43%
EPS Next 2Y6.17%
EPS Next 3Y5.25%
EPS Next 5Y4.48%
Revenue Next Year9.42%
Revenue Next 2Y5.5%
Revenue Next 3Y4.54%
Revenue Next 5Y3.55%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
1AMGN is valuated correctly with a Price/Earnings ratio of 14.91.
Based on the Price/Earnings ratio, 1AMGN is valued cheaper than 86.75% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.39, 1AMGN is valued a bit cheaper.
1AMGN is valuated correctly with a Price/Forward Earnings ratio of 14.60.
Based on the Price/Forward Earnings ratio, 1AMGN is valued cheaply inside the industry as 93.98% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 23.84. 1AMGN is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.91 | ||
| Fwd PE | 14.6 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1AMGN indicates a rather cheap valuation: 1AMGN is cheaper than 80.72% of the companies listed in the same industry.
90.36% of the companies in the same industry are more expensive than 1AMGN, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.77 | ||
| EV/EBITDA | 12.5 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of 1AMGN may justify a higher PE ratio.
PEG (NY)1.58
PEG (5Y)2.5
EPS Next 2Y6.17%
EPS Next 3Y5.25%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 3.11%, 1AMGN has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 0.80, 1AMGN pays a better dividend. On top of this 1AMGN pays more dividend than 97.59% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 1.87, 1AMGN pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.11% |
5.2 History
On average, the dividend of 1AMGN grows each year by 9.41%, which is quite nice.
Dividend Growth(5Y)9.41%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
17.20% of the earnings are spent on dividend by 1AMGN. This is a low number and sustainable payout ratio.
1AMGN's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP17.2%
EPS Next 2Y6.17%
EPS Next 3Y5.25%
BIT:1AMGN (12/8/2025, 7:00:00 PM)
278.45
-16.45 (-5.58%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners83.83%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap149.94B
Revenue(TTM)35.97B
Net Income(TTM)7.00B
Analysts72.2
Price Target289.78 (4.07%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.11% |
Yearly Dividend7.7
Dividend Growth(5Y)9.41%
DP17.2%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.96%
Min EPS beat(2)10.28%
Max EPS beat(2)11.64%
EPS beat(4)4
Avg EPS beat(4)9.04%
Min EPS beat(4)2.49%
Max EPS beat(4)11.73%
EPS beat(8)7
Avg EPS beat(8)5.13%
EPS beat(12)10
Avg EPS beat(12)4.44%
EPS beat(16)14
Avg EPS beat(16)4.21%
Revenue beat(2)2
Avg Revenue beat(2)2.59%
Min Revenue beat(2)0.68%
Max Revenue beat(2)4.49%
Revenue beat(4)3
Avg Revenue beat(4)1.17%
Min Revenue beat(4)-0.84%
Max Revenue beat(4)4.49%
Revenue beat(8)3
Avg Revenue beat(8)-0.21%
Revenue beat(12)4
Avg Revenue beat(12)-0.48%
Revenue beat(16)5
Avg Revenue beat(16)-0.54%
PT rev (1m)5.64%
PT rev (3m)3.43%
EPS NQ rev (1m)0.07%
EPS NQ rev (3m)-11.17%
EPS NY rev (1m)1.12%
EPS NY rev (3m)2.12%
Revenue NQ rev (1m)-0.04%
Revenue NQ rev (3m)1.93%
Revenue NY rev (1m)1.86%
Revenue NY rev (3m)2.89%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.91 | ||
| Fwd PE | 14.6 | ||
| P/S | 4.88 | ||
| P/FCF | 13.77 | ||
| P/OCF | 13.38 | ||
| P/B | 18.26 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.5 |
EPS(TTM)18.67
EY6.7%
EPS(NY)19.08
Fwd EY6.85%
FCF(TTM)20.22
FCFY7.26%
OCF(TTM)20.81
OCFY7.47%
SpS57.04
BVpS15.25
TBVpS-51.05
PEG (NY)1.58
PEG (5Y)2.5
Graham Number80.04
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.77% | ||
| ROE | 72.82% | ||
| ROCE | 17.67% | ||
| ROIC | 15.39% | ||
| ROICexc | 17.86% | ||
| ROICexgc | 61.56% | ||
| OM | 33.57% | ||
| PM (TTM) | 19.47% | ||
| GM | 72.06% | ||
| FCFM | 35.46% |
ROA(3y)7.14%
ROA(5y)8.52%
ROE(3y)118.78%
ROE(5y)104.3%
ROIC(3y)13.04%
ROIC(5y)14.18%
ROICexc(3y)15.77%
ROICexc(5y)17.27%
ROICexgc(3y)75.76%
ROICexgc(5y)77.1%
ROCE(3y)14.97%
ROCE(5y)16.28%
ROICexgc growth 3Y3.26%
ROICexgc growth 5Y-18.2%
ROICexc growth 3Y-8.67%
ROICexc growth 5Y-7.85%
OM growth 3Y-6.36%
OM growth 5Y-7.03%
PM growth 3Y-18.6%
PM growth 5Y-18.28%
GM growth 3Y-2.94%
GM growth 5Y-3.32%
F-Score7
Asset Turnover0.4
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.45 | ||
| Debt/FCF | 4.28 | ||
| Debt/EBITDA | 2.97 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 74.3% | ||
| Profit Quality | 182.08% | ||
| Current Ratio | 1.28 | ||
| Quick Ratio | 0.99 | ||
| Altman-Z | N/A |
F-Score7
WACC8.49%
ROIC/WACC1.81
Cap/Depr(3y)24.77%
Cap/Depr(5y)23.42%
Cap/Sales(3y)3.59%
Cap/Sales(5y)3.31%
Profit Quality(3y)165.92%
Profit Quality(5y)155.23%
High Growth Momentum
Growth
EPS 1Y (TTM)13.79%
EPS 3Y5.02%
EPS 5Y5.97%
EPS Q2Q%1.08%
EPS Next Y9.43%
EPS Next 2Y6.17%
EPS Next 3Y5.25%
EPS Next 5Y4.48%
Revenue 1Y (TTM)10.56%
Revenue growth 3Y8.76%
Revenue growth 5Y7.43%
Sales Q2Q%12.4%
Revenue Next Year9.42%
Revenue Next 2Y5.5%
Revenue Next 3Y4.54%
Revenue Next 5Y3.55%
EBIT growth 1Y93.73%
EBIT growth 3Y1.84%
EBIT growth 5Y-0.13%
EBIT Next Year42.82%
EBIT Next 3Y11.34%
EBIT Next 5Y7.32%
FCF growth 1Y36%
FCF growth 3Y7.44%
FCF growth 5Y4.03%
OCF growth 1Y24.04%
OCF growth 3Y7.45%
OCF growth 5Y4.66%
AMGEN INC / 1AMGN.MI FAQ
Can you provide the ChartMill fundamental rating for AMGEN INC?
ChartMill assigns a fundamental rating of 5 / 10 to 1AMGN.MI.
Can you provide the valuation status for AMGEN INC?
ChartMill assigns a valuation rating of 6 / 10 to AMGEN INC (1AMGN.MI). This can be considered as Fairly Valued.
How profitable is AMGEN INC (1AMGN.MI) stock?
AMGEN INC (1AMGN.MI) has a profitability rating of 7 / 10.
What is the valuation of AMGEN INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for AMGEN INC (1AMGN.MI) is 14.91 and the Price/Book (PB) ratio is 18.26.
What is the financial health of AMGEN INC (1AMGN.MI) stock?
The financial health rating of AMGEN INC (1AMGN.MI) is 3 / 10.